BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Policy

  CryoLife, Inc. To Receive $2.25 Million To Settle Dispute

  October 2, 2006

   · 

  3 min read
• Drug Development

  Merck & Co., Inc. Release: REPEAT/Viral Suppression In Triple-Class Drug Resistant Patients Maintained After 24 Weeks Of Treatment With MK-0518, An Investigational HIV Integrase Inhibitor, Plus Optimized Background Therapy (OBT)

  October 2, 2006

   · 

  6 min read
• Business

  Vascular Solutions To Webcast Third Quarter Conference Call Thursday, October 19, 2006 At 3:30pm CST

  October 2, 2006

   · 

  1 min read
• Drug Development

  Human Genome Sciences, Inc. Reports Positive Results Of Phase 1 Clinical Trial Of CCR5 mAb In Patients Infected With HIV-1

  October 2, 2006

   · 

  8 min read
• Business

  Edison Pharmaceuticals, Inc. And Institute Of Vision Enter Into Collaboration

  October 2, 2006

   · 

  3 min read
• Genetown

  Boston Scientific Corporation Announces Major Expansion Of Its LATITUDE(R) Patient Management System

  October 2, 2006

   · 

  3 min read
• Mistral Pharma Inc. Grants Stock Options

  October 2, 2006

   · 

  1 min read
• Business

  Biotel Inc. Announces Revenues And Earnings For The Quarter And Year Ended June 30, 2006

  October 2, 2006

   · 

  2 min read
• BioForest

  Inflazyme Pharmaceuticals Ltd. Announces Date Of Its Annual General And Special Shareholders’ Meeting

  October 2, 2006

   · 

  1 min read
• BioForest

  Meridian Co. Ltd. Corporate Update

  October 2, 2006

   · 

  1 min read